Literature DB >> 3690228

Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma.

M W Kissin1, D A Simpson, D Easton, H White, G Westbury.   

Abstract

A retrospective analysis was carried out of 133 patients undergoing therapeutic lymph node dissection for malignant melanoma of the lower limb. A radical ilio-obturator dissection (RID) was performed in 106 patients and a superficial femoral dissection (SFD) in the remaining 27. On univariate analysis five factors were found to be significant indicators of prognosis. These were: Clark level of the primary (P = 0.02); primary melanoma thickness (P = 0.04); total number of positive nodes (P less than 0.001); number of positive femoral nodes (P less than 0.001); and number of positive ilio-obturator nodes (P less than 0.001). On multiple regression analysis only the number of positive nodes in each compartment remained a significant independent factor (P less than 0.001). The morbidity associated with RID was not significantly greater than after SFD. RID was, however, associated with a reduction in subsequent groin recurrence. Radical nodal clearance is the operation of choice. This technique provides maximum prognostic information, reduces the likelihood of local untreatable disease and possibly improves overall survival rates--especially when only one iliac node is involved.

Entities:  

Mesh:

Year:  1987        PMID: 3690228     DOI: 10.1002/bjs.1800741122

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Combined endoscopic and open inguinal dissection for malignant melanoma.

Authors:  Claus Schneider; Jens P Brodersen; Hubert Scheuerlein; Carsten Tamme; Hans Lippert; Ferdinand Köckerling
Journal:  Langenbecks Arch Surg       Date:  2003-03-11       Impact factor: 3.445

2.  Stage III thick (>4.0 mm) lower extremity melanoma: is timing of lymph node involvement a prognostic factor?

Authors:  Krzysztof Herman; Wojciech M Wysocki; Piotr Skotnicki; Jacek Tabor; Elebieta Luczyńska; Andrzej L Komorowski
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

3.  [Inguinal recurrence after therapeutic lymphadenectomy in malignant melanoma].

Authors:  L Kretschmer; C Lautenschläger; K P Preusser; H Fiedler
Journal:  Langenbecks Arch Chir       Date:  1993

4.  [Axillary recurrence after lymph node excision in malignant melanoma].

Authors:  L Kretschmer; C Lautenschläger; K P Preusser; H Fiedler; I Hetschko
Journal:  Langenbecks Arch Chir       Date:  1993

5.  Axillary dissection in melanoma. Prognostic variables in node-positive patients.

Authors:  R G Bevilacqua; D G Coit; A Rogatko; R N Younes; M F Brennan
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

6.  Role of radiotherapy in melanoma management.

Authors:  Primoz Strojan
Journal:  Radiol Oncol       Date:  2010-03-18       Impact factor: 2.991

7.  Cell kinetics: an independent prognostic variable in stage II melanoma of the skin.

Authors:  A Costa; R Silvestrini; G Mezzanotte; M Vaglini; E Grignolio; C Clemente; N Cascinelli
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.

Authors:  Nicola Mozzillo; Corrado Caracò; Ugo Marone; Gianluca Di Monta; Anna Crispo; Gerardo Botti; Maurizio Montella; Paolo Antonio Ascierto
Journal:  World J Surg Oncol       Date:  2013-02-04       Impact factor: 2.754

9.  Nodal Basin Recurrence After Sentinel Lymph Node Biopsy for Melanoma: A Retrospective Multicenter Study in 2653 Patients.

Authors:  Lutz Kretschmer; Hans Peter Bertsch; Antonia Zapf; Christina Mitteldorf; Imke Satzger; Kai-Martin Thoms; Bernward Völker; Michael Peter Schön; Ralf Gutzmer; Hans Starz
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.